Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

437
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
437
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

232
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
232
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

817
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
817
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

361
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
361
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

895
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
895
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

116
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
116

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review.

International forum of allergy & rhinology·2026
Same author

Reply to "Elimination diet and formula choice in the management of food protein-induced allergic proctocolitis (FPIAP)".

The journal of allergy and clinical immunology. In practice·2026
Same author

When IgE means more-and less-than allergy: Rethinking food sensitization in cardiovascular disease.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

PloS one·2026
Same author

Shared Decision-Making and Health-Related Quality of Life in Drug Allergy.

The journal of allergy and clinical immunology. In practice·2026
Same author

The story of aluminium containing vaccines is bigger than any one study.

BMJ (Clinical research ed.)·2026

Related Experiment Video

Updated: Aug 31, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.5K

Diphenhydramine: Time to Move on?

Anna R Wolfson1, Dennis Wong2, Elissa M Abrams3

  • 1Harvard Medical School, Boston, Mass; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.

The Journal of Allergy and Clinical Immunology. in Practice
|August 23, 2022
PubMed
Summary

Diphenhydramine, an older antihistamine, causes significant side effects like sedation and overdose toxicity. Newer, safer second-generation antihistamines offer similar benefits with fewer risks, making diphenhydramine obsolete.

Keywords:
AntihistaminesCetirizineDiphenhydramineFexofenadine

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.1K
Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid
07:06

Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid

Published on: November 15, 2017

11.5K

Related Experiment Videos

Last Updated: Aug 31, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.5K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.1K
Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid
07:06

Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid

Published on: November 15, 2017

11.5K

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Drug Safety

Background:

  • Diphenhydramine is a widely accessible, long-standing antihistamine.
  • Despite its availability, diphenhydramine is associated with notable adverse effects, including sedation and significant toxicity risks in overdose scenarios, such as cardiac complications.
  • Its use is often inappropriate, especially when superior alternatives exist.

Purpose of the Study:

  • To evaluate the continued clinical relevance of diphenhydramine.
  • To compare the risk-benefit profile of diphenhydramine against second-generation antihistamines.
  • To advocate for the transition away from diphenhydramine in favor of safer alternatives.

Main Methods:

  • Literature review of antihistamine efficacy and safety profiles.
  • Comparative analysis of side effect profiles and toxicity risks.
  • Assessment of current clinical guidelines and prescribing practices.

Main Results:

  • Diphenhydramine exhibits a high incidence of sedation and a concerning toxicity profile in overdose.
  • Second-generation antihistamines provide comparable therapeutic effects with a significantly improved safety margin.
  • These newer agents are readily available and cost-effective.

Conclusions:

  • The risks associated with diphenhydramine, including sedation and overdose toxicity, outweigh its benefits.
  • Safer and equally effective second-generation antihistamines are widely available and affordable.
  • Clinical practice should transition away from diphenhydramine towards preferred, safer antihistamine options.